EPICYPHER, INC.

EpiCypher

Durham, United States · Founded 2015 · $36.8M raised

Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$36.8M
Last Round
$1.0M GrantAug 2025
Rounds
25

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

EpiCypher is a Durham, NC-based epigenetics company and global leader in recombinant nucleosome manufacturing, founded in 2012 by leading chromatin biology researchers. The company develops CUTANA genomic mapping assays, designer nucleosomes, and epigenetics reagents and services used by academic and biopharma researchers to advance chromatin biology and drug development.

Summary

EPICYPHER, INC. is a Biotech company based in Durham, United States, founded in 2015. It has raised $36.8M in total across 25 rounds, most recently a $1.0M Grant round in Aug 2025.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase II (NIH)Aug 2025
$1.0M

Sign up to see all 25 events

Funding: Grant. Amounts, valuations, and investors where available.

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech, Drug Discovery
Extension RoundTotal funding$821.8MSep 2025
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Chai Discovery

Chai Discovery builds frontier AI to predict and reprogram interactions between biochemical molec...

San Francisco, United States11–50Artificial Intelligence, Biotech
Series CTotal funding$630.0MJul 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

EPICYPHER, INC. on Indexed.vc
<a href="https://indexed.vc/companies/epicypher-inc"><img src="https://indexed.vc/api/badge/company/epicypher-inc" alt="EPICYPHER, INC. on Indexed.vc" width="260" height="76" /></a>